Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study

Turner, M.R, Cagnin, A, Turkheimer, F.E, Miller, C.C.J, Shaw, C.E, Brooks, D.J, Leigh, P.N, Banati, R.B·2004·Neurobiology of Disease
DOI 10.1016/j.nbd.2003.12.012

Cited by (737)

Items 501–600 of 737

  1. Structural and Functional Brain Network Connectivity at Different King's Stages in Patients With Amyotrophic Lateral Sclerosis
    Edoardo Gioele Spinelli, Alma Ghirelli, Silvia Basaia, Elisa Canu, Veronica Castelnovo, Camilla Cividini, Tommaso Russo, Paride Schito, Yuri Falzone, Nilo Riva et al. · 2023 · Neurology
  2. The Current Potential Pathogenesis of Amyotrophic Lateral Sclerosis
    Shishi Jiang, Renshi Xu · 2024 · Molecular Neurobiology
  3. Image Derived Input Function for [18F]-FEPPA: Application to Quantify Translocator Protein (18 kDa) in the Human Brain
    Rostom Mabrouk, Pablo Rusjan, Romina Mizrahi, Mark F. Jacobs, Yuko Koshimori, Sylvain Houle, Ji Hyun Ko, Antonio P. Strafella · 2014 · PLoS ONE
  4. Identification of receptors and enzymes for endocannabinoids in NSC-34 cells: Relevance for in vitro studies with cannabinoids in motor neuron diseases
    Miguel Moreno‐Martet, Leyre Mestre, Frida Loría, Carmen Guaza, Javier Fernández‐Ruíz, Eva de Lago · 2011 · Neuroscience Letters
  5. Differential Impairment of Thalamocortical Structural Connectivity in Amyotrophic Lateral Sclerosis
    Jiuquan Zhang, Bing Ji, Chaoyang Zhou, Longchuan Li, Zhi‐Hao Li, Xiaoping Philip Hu, Jun Hu · 2016 · CNS Neuroscience & Therapeutics
  6. Fiber‐specific white matter analysis reflects upper motor neuron impairment in amyotrophic lateral sclerosis
    A. Ogura, Kazuya Kawabata, Hirohisa Watanabe, S. Choy, E. Bagarinao, Toshiyasu Kato, K. Imai, Michihito Masuda, R. Ohdake, K. Hara et al. · 2021 · European Journal of Neurology
  7. Dysfunction of RNA/RNA-Binding Proteins in ALS Astrocytes and Microglia
    Simona Rossi, Mauro Cozzolino · 2021 · Cells
  8. Role of NCKAP1 in the Defective Phagocytic Function of Microglia-Like Cells Derived from Rapidly Progressing Sporadic ALS
    Min‐Young Noh, Min‐Soo Kwon, Ki‐Wook Oh, Minyeop Nahm, Jinseok Park, Young-Eun Kim, Chang‐Seok Ki, Hee Kyung Jin, Jae‐sung Bae, Seung Hyun Kim · 2023 · Molecular Neurobiology
  9. Cognitive, behavioral, and brain functional connectivity correlates of fatigue in amyotrophic lateral sclerosis
    Francesca Trojsi, Federica Di Nardo, Giulia D’Alvano, Carla Passaniti, Minoo Sharbafshaaer, Fabrizio Canale, Antonio Russo, Marcello Silvestro, Luigi Lavorgna, Mario Cirillo et al. · 2023 · Brain and Behavior
  10. Allopregnanolone and its antagonist modulate neuroinflammation and neurological impairment
    Torbjörn Carl Bäckström, Magnus Doverskog, Thomas P. Blackburn, Bruce F. Scharschmidt, Vicente Felipo · 2024 · Neuroscience & Biobehavioral Reviews
  11. Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic dysfunction and progressive motor deficits
    Yiying Hu, Alexander Hruscha, Chenchen Pan, Martina Schifferer, Michael K. Schmidt, Brigitte Nuscher, Martin A. Giera, Sarantos Kostidis, Özge Pelin Burhan, Frauke van Bebber et al. · 2024 · Molecular Neurodegeneration
  12. Non-Motor Symptoms of Amyotrophic Lateral Sclerosis: A Multi-Faceted Disorder
    Yuval Nash, Michal Sitty · 2021 · Journal of Neuromuscular Diseases
  13. Assessing the upper motor neuron in amyotrophic lateral sclerosis using the triple stimulation technique: A multicenter prospective study
    Aude‐Marie Grapperon, Annie Verschueren, Élisabeth Jouve, Régine Morizot-Koutlidis, Timothée Lenglet, Pierre‐François Pradat, François Salachas, E Bernard, Stéphanie Delstanche, Alain Maertens de Noordhout et al. · 2021 · Clinical Neurophysiology
  14. Combined Treatment with Bojungikgi-Tang and Riluzole Regulates Muscle Metabolism and Dysfunction in the hSOD1G93A Mouse Model
    Mudan Cai, Eun Jin Yang · 2022 · Antioxidants
  15. Monocyte Chemoattractant Protein-1 upregulates GABA-induced current: Evidence of modified GABAA subunit composition in cortical neurons from the G93A mouse model of Amyotrophic Lateral Sclerosis
    Silvia Caioli, Massimo Pieri, Alessia Antonini, Angelo Guglielmotti, Cinzia Severini, Cristina Zona · 2013 · Neuropharmacology
  16. A Possible Role for Platelet-Activating Factor Receptor in Amyotrophic Lateral Sclerosis Treatment
    Marcelo R. S. Briones, Amanda M. Snyder, Renata C. Ferreira, Elizabeth B. Neely, James R. Connor, James Riley Broach · 2018 · Frontiers in Neurology
  17. Amyotrophic Lateral Sclerosis, Primary Lateral Sclerosis and Spinal Muscular Atrophy
    Michael Joseph Strong, Tibor Hortobágyi, Koichi Okamoto, Shinsuke Kato · 2011 · Wiley eBooks
  18. Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: Neuropathological and positron emission tomography molecular neuroimaging evidence
    Amanda M. Dios, Suma Babu, Eric J. Granucci, Kaly A. Mueller, Alexandra N. Mills, Mohamad J. Alshikho, Nicole R. Zürcher, Paul Cernasov, Tonya M. Gilbert, Jonathan D. Glass et al. · 2019 · Muscle & Nerve
  19. Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials
    Andrea Barp, Francesca Gerardi, Andrea Lizio, Valeria Sansone, Christian Lunetta · 2020 · Expert Opinion on Emerging Drugs
  20. Disease propagation in amyotrophic lateral sclerosis (ALS): an interplay between genetics and environment
    Sarah Schram, Jeffrey A. Loeb, Fei Song · 2020 · Journal of Neuroinflammation
  21. Small Molecule Receptors as Imaging Targets
    Aviv Hagooly, Raffaella Rossin, Michael John Welch · 2008 · Handbook of experimental pharmacology
  22. Human Dosimetry of Carbon-11 Labeled N-butan-2-yl-1-(2-chlorophenyl)-N-methylisoquinoline-3-carboxamide Extrapolated from Whole-body Distribution Kinetics and Radiometabolism in Rats
    Pauliina Luoto, Iina Laitinen, Sami Suilamo, Kjell Någren, Anne Roivainen · 2009 · Molecular Imaging and Biology
  23. New developments and future opportunities in biomarkers for amyotrophic lateral sclerosis
    Xueping Chen, Huifang Shang · 2015 · Translational Neurodegeneration
  24. Anti-Inflammatory Effects of Miyako Bidens pilosa in a Mouse Model of Amyotrophic Lateral Sclerosis and Lipopolysaccharide-Stimulated BV-2 Microglia
    Komugi Tsuruta, Takato Shidara, Hiroko Miyagishi, Hiroshi Nango, Yoshihiko Nakatani, Naoto Suzuki, Taku Amano, Toyofumi Suzuki, Yasuhiro Kosuge · 2023 · International Journal of Molecular Sciences
  25. Human amyotrophic lateral sclerosis/motor neuron disease: The disease‐associated microglial pathway is upregulated while APOE genotype governs risk and survival
    Bridget Ashford, Julie E. Simpson, Charlotte Dawson, Delphine Boche, Johnathan Cooper‐Knock, Paul Roy Heath, Daniel J. Fillingham, Charlie Appleby‐Mallinder, Wenbin Wei, Mark Dunning et al. · 2025 · Brain Pathology
  26. GMP-compliant fully automated radiosynthesis of [18F]FEPPA for PET/MRI imaging of regional brain TSPO expression
    Chi-Wei Chang, Chuang-Hsin Chiu, Ming-Hsien Lin, Hung‐Ming Wu, Tsung-Hsun Yu, Pao-Yeh Wang, Yu-Yeh Kuo, Ya-Yao Huang, Chyng‐Yann Shiue, Wen-Sheng Huang et al. · 2021 · EJNMMI Research
  27. The Translocator Protein (TSPO) Genetic Polymorphism A147T Is Associated with Worse Survival in Male Glioblastoma Patients
    Katie M. Troike, Arlet Acanda de la Rocha, Tyler Joseph Alban, Matthew M. Grabowski, Balint Otvos, Gino Cioffi, Kristin A. Waite, Jill S. Barnholtz‐Sloan, Justin Durla Lathia, Tomás R. Guilarte et al. · 2021 · Cancers
  28. Novel Indications for Benzodiazepine Antagonist Flumazenil in GABA Mediated Pathological Conditions of the Central Nervous System
    Gary Kenneth Hulse, Erin A. Kelty, Sean D. Hood, Amanda F. Norman, Maria Basso, Albert Stuart Reece · 2015 · Current Pharmaceutical Design
  29. Comparison of Two Clinical Upper Motor Neuron Burden Rating Scales in ALS Using Quantitative Brain Imaging
    Meena M. Makary, Akila Weerasekara, Haley Rodham, Baileigh G. Hightower, Chieh-En Jane Tseng, James Gin Man Chan, Sheena Chew, Sabrina Paganoni, Eva‐Maria Ratai, Nicole R. Zürcher et al. · 2021 · ACS Chemical Neuroscience
  30. Role of Glia in CNS Inflammation
    Siddharama Pawate, Narayan R. Bhat · 2007 · Springer eBooks
  31. Longitudinal evaluation of upper motor neuron burden scales in primary lateral sclerosis
    Mary Kay Floeter, Tianxia Wu · 2020 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  32. SOD1G93A transgenic mouse CD4+ T cells mediate neuroprotection after facial nerve axotomy when removed from a suppressive peripheral microenvironment
    Nichole A. Mesnard, Junping Xin, Melissa M. Haulcomb, Richard J. Batka, Virginia M. Sanders, Kathryn J. Jones · 2014 · Brain Behavior and Immunity
  33. Novel therapeutic targets for amyotrophic lateral sclerosis: ribonucleoproteins and cellular autonomy
    Yiran Wang, Rickie Patani · 2020 · Expert Opinion on Therapeutic Targets
  34. Different Frontal Involvement in ALS and PLS Revealed by Stroop Event-Related Potentials and Reaction Times
    Ninfa Amato, Nilo Riva, Marco Cursi, ANA CESARINA FERREIRA DA SILVA, Vittorio Martinelli, Mauro Comola, Raffaella Fazio, Gıancarlo Comı, Letizia Leocani · 2013 · Frontiers in Aging Neuroscience
  35. The Service Hospitalier Frédéric Joliot – contributions to PET chemistry over the years
    Dirk Roeda, Bertrand Kühnast, Akli Hammadi, Frédéric Dollé · 2007 · Journal of Labelled Compounds and Radiopharmaceuticals
  36. Astrocyte–Neuron Communications
    Sally R. McIver, Mathilde Faideau, Philip G. Haydon · 2012 · Springer eBooks
  37. Relevance of raised cerebrospinal fluid monocyte levels in patients with frontotemporal dementia
    Matthias Pawlowski, Gero Lueg, Catharina C. Groß, Andreas Johnen, Julia Krämer, Matthias Weckesser, Heinz Wiendl, Sven Guenther Meuth, Thomas Duning · 2017 · Neurobiology of Aging
  38. Loss of CREST leads to neuroinflammatory responses and ALS-like motor defects in mice
    Cheng Cheng, Kan Yang, Xinwei Wu, Yuefang Zhang, Shifang Shan, Aaron D. Gitler, Anirvan Ghosh, Zilong Qiu · 2019 · Translational Neurodegeneration
  39. ALS, what new 144 years after Charcot?
    Vincent Meininger · 2011 · PubMed
  40. Involvement of Lipids in the Pathogenesis of Amyotrophic Lateral Sclerosis
    Alisa V. Alessenko, У. А. Гутнер, Maria A. Shupik · 2023 · Life
  41. Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer’s Disease or Other Neurological Diseases
    Takeshi Kawarabayashi, Takumi Nakamura, Kazuya Miyashita, Tatsuya Segawa, Isamu Fukamachi, Takashi Sugawara, Hironori Oka, Kunihiko Ishizawa, Masakuni Amari, Hiroo Kasahara et al. · 2023 · Journal of Alzheimer s Disease
  42. Neurodegeneration and the immune system: lessons from autoimmune encephalitis
    Lucia Campetella, Krzysztof Smolik, Antonio Farina, Bastien Joubert, Sergio Muñiz‐Castrillo, Virginie Desestret, Jérôme Honnorat · 2025 · Journal of Neurology
  43. Molecular Neuroimaging: The Basics
    Lucia Le Roux, Dawid Schellingerhout · 2013 · Seminars in Roentgenology
  44. Magnetic resonance imaging of pathological processes in rodent models of amyotrophic lateral sclerosis
    Matthew C. Evans, Michel Modo, Kevin Talbot, Niki Sibson, Martin R. Turner · 2011 · Amyotrophic Lateral Sclerosis
  45. Hypoxic stress visualized in the cervical spinal cord of ALS patients
    Toru Yamashita, Tetsuhiro Hatakeyama, Kota Sato, Yusuke Fukui, Nozomi Hishikawa, Mami Takemoto, Yasuyuki Ohta, Yoshihiro Nishiyama, Nobuyuki Kawai, Takashi Tamiya et al. · 2020 · Neurological Research
  46. Imaging immunological processes from blood to brain in amyotrophic lateral sclerosis
    Sandra Amor, Erik Nutma, Manuel C. Marzin, Fabìola Puentes · 2021 · Clinical & Experimental Immunology
  47. The Role of Microglial Cells in Amyotrophic Lateral Sclerosis
    Patrick Weydt, Thomas Möller · 2005 · Physical Medicine and Rehabilitation Clinics of North America
  48. Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks
    Stefanie M. A. Willekens, Donatienne Van Weehaeghe, Philip Van Damme, Koen Van Laere · 2016 · European Journal of Nuclear Medicine and Molecular Imaging
  49. La sclérose latérale primitive : l’avènement de critères consensuels internationaux
    Nadine Le Forestier, Vincent Meininger · 2008 · Revue Neurologique
  50. Muscle ultrasound aids diagnosis in amyotrophic lateral sclerosis
    Andrew P. Hannaford, Nathan Pavey, Parvathi Menon, Mehdi A. J. van den Bos, Matthew C. Kiernan, Neil G. Simon, Steve Vucic · 2024 · Clinical Neurophysiology
  51. 4-Phenylbutyric Acid (4-PBA) Derivatives Prevent SOD1 Amyloid Aggregation In Vitro with No Effect on Disease Progression in SOD1-ALS Mice
    Leenor Alfahel, Shirel Argueti-Ostrovsky, Shir Barel, Mahmood Ali Saleh, Joy Kahn, Salome Azoulay‐Ginsburg, Ayelet Rothstein, Simon Ebbinghaus, Arie Gruzman, Adrian Israelson · 2022 · International Journal of Molecular Sciences
  52. Aberrant Multimodal Connectivity Pattern Involved in Default Mode Network and Limbic Network in Amyotrophic Lateral Sclerosis
    Haifeng Chen, Zheqi Hu, Zhihong Ke, Yun Xu, Feng Bai, Zhuo Liu · 2023 · Brain Sciences
  53. Coupling motor evoked potentials and brain [18F]FDG-PET in Amyotrophic Lateral Sclerosis: preliminary findings on disease severity
    Giacomo Tondo, Letizia Mazzini, Silvia Paola Caminiti, Chiara Gallo, Roberta Matheoud, Cristoforo Comi, Gian Mauro Sacchetti, Daniela Perani, Fabiola De Marchi · 2024 · Neurobiology of Disease
  54. Cortical inexcitability in ALS: correlating a clinical phenotype
    Nathan Pavey, Andrew P. Hannaford, Mana Higashihara, Mehdi A. J. van den Bos, Nimeshan Geevasinga, Steve Vucic, Parvathi Menon · 2024 · Journal of Neurology Neurosurgery & Psychiatry
  55. Progressive hemiparesis in a 75-year-old man
    Peter M. Fernandes, Martin R. Turner, Martin Zeidler, Colin Smith, Richard Davenport · 2014 · Practical Neurology
  56. Brain neurovascular coupling in amyotrophic lateral sclerosis: Correlations with disease progression and cognitive impairment
    Francesca Trojsi, Antonietta Canna, Minoo Sharbafshaaer, Federica Di Nardo, Fabrizio Canale, Carla Passaniti, Maria Agnese Pirozzi, Marcello Silvestro, Ilaria Orologio, Antonio Russo et al. · 2024 · European Journal of Neurology
  57. Measuring disease progression in primary lateral sclerosis
    Madison Gilmore, Lauren B. Elman, Suma Babu, Patricia L. Andres, Mary Kay Floeter · 2020 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  58. Magnetic Source Imaging of Cortical Dysfunction in Amyotrophic Lateral Sclerosis
    Robert A. Boyajian, Carlos Amo, Shirley M. Otis, John S. Romine, Richard Alan Smith · 2008 · American Journal of Physical Medicine & Rehabilitation
  59. Glial Cells in ALS: The Missing Link?
    Elsa Raibon, Lisa Marie Todd, Thomas Möller · 2008 · Physical Medicine and Rehabilitation Clinics of North America
  60. Cell–cell communication by Endocannabinoids during Immune Surveillance of the Central Nervous System
    Oliver Ullrich, Regine Schneider‐Stock, Frauke Zipp · 2006 · Springer eBooks
  61. Does neuroinflammation sustain neurodegeneration in ALS?
    Massimo Filippi, Federica Agosta · 2016 · Neurology
  62. Glial Cells as Key Mediators in the Pathophysiology of Neurodegenerative Diseases
    Katarzyna Bogus, Nicoletta Marchesi, Lucrezia Irene Maria Campagnoli, Alessia Pascale, Artur Pałasz · 2026 · International Journal of Molecular Sciences
  63. Current neuroprotective therapies and future prospects for motor neuron disease
    Laura J. Evans, David O’Brien, Pamela J. Shaw · 2024 · International review of neurobiology
  64. Microglial Positron Emission Tomography Imaging In Vivo
    Julie Ottoy, Livia De Picker, Min Su Kang · 2024 · Advances in neurobiology
  65. Microglia in the Physiology and Pathology of Brain
    Aarti Nagayach, Nisha Patro, Ishan Kumar Patro · 2015 · Proceedings of the National Academy of Sciences India Section B Biological Sciences
  66. Histology, Glial Cells
    Parker E. Ludwig, Joe M Das · 2019 · StatPearls Publishing, Treasure Island (FL) eBooks
  67. Syndrome de Mills : une entité clinique rare
    Sylvain Lachaud, Marie‐Hélène Soriani, Émilien Delmont, M. Budai, Claude Desnuelle, Christine Lebrun‐Frénay · 2007 · Revue Neurologique
  68. Movement-related cortical potentials in ALS increase at lower and decrease at higher upper motor neuron burden scores
    N. Bizovičar, B. Koritnik, I. Zidar, Jurij Dreo, J. Zidar · 2013 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  69. Reduction of inflammation and mitochondrial degeneration in mutant SOD1 mice through inhibition of voltage-gated potassium channel Kv1.3
    Patrizia Ratano, Germana Cocozza, Cecilia Pinchera, Ludovica Maria Busdraghi, Iva Cantando, Katiuscia Martinello, Mariarosaria Scioli, Maria Rosito, Paola Bezzi, Sergio Fucile et al. · 2024 · Frontiers in Molecular Neuroscience
  70. Quantitative spinal cord imaging: Early ALS diagnosis and monitoring of disease progression
    Mohammed Khamaysa, Mohamed Mounir El Mendili, Véronique Marchand‐Pauvert, Giorgia Querin, Pierre‐François Pradat · 2024 · Revue Neurologique
  71. A comprehensive update on neuroimaging endpoints in amyotrophic lateral sclerosis
    Massimo Filippi, Alma Ghirelli, Edoardo Gioele Spinelli, Federica Agosta · 2025 · Expert Review of Neurotherapeutics
  72. MND Phenotypes Differentiation: The Role of Multimodal Characterization at the Time of Diagnosis
    Giuseppe Meo, Pilar M. Ferraro, Marta Cillerai, Chiara Gemelli, Corrado Cabona, Federico Zaottini, Luca Roccatagliata, Flavio S. Villani, Angelo E. Schenone, Claudia Caponnetto · 2022 · Life
  73. Association of peripheral immune activation with amyotrophic lateral sclerosis and Parkinson's disease: A systematic review and meta-analysis
    Han Wang, Yi-Ti Liu, Yanling Ren, Xiaoyan Guo, Yi Wang · 2024 · Journal of Neuroimmunology
  74. Identification of B6SJL mSOD1G93A mouse subgroups with different disease progression rates
    Melissa M. Haulcomb, Nichole A. Mesnard, Richard J. Batka, Rena M. Meadows, Whitney M. Miller, Kathryn P. McMillan, Todd J. Brown, Virginia M. Sanders, Kathryn J. Jones · 2015 · The Journal of Comparative Neurology
  75. Amelioration of Amyotrophic Lateral Sclerosis in SOD1G93AMice by M2Microglia from Transplanted Marrow
    Michael W. Epperly, Renee Fisher, Lora Heather Rigatti, Simon C. Watkins, Xichen Zhang, WEN HOU, Donna S. Shields, Darcy Franicola, Hülya Bayır, Hong Wang et al. · 2019 · In Vivo
  76. ALSUntangled No. 19: Sodium chlorite
    The ALSUntangled Group · 2013 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  77. Role of Amyloidogenic and Non‐Amyloidogenic Protein Spaces in Neurodegenerative Diseases and their Mitigation Using Theranostic Agents
    Kapali Suri, Madhu Ramesh, Mansi Bhandari, Vishakha Gupta, Virendra Kumar, Thimmaiah Govindaraju, N. Arul Murugan · 2024 · ChemBioChem
  78. Amyotrophic lateral sclerosis: mechanisms and therapeutic strategies
    Ludo Van Den Bosch · 2017 · Elsevier eBooks
  79. Neuroglia in Neurological Diseases
    Alexei Verkhratsky, Arthur Morgan Butt · 2013 · Wiley eBooks
  80. Role of 2-[18F]FDG-PET as a biomarker of upper motor neuron involvement in amyotrophic lateral sclerosis
    Sara Cabras, Umberto Manera, Francesca Di Pede, Grazia Zocco, Rosario Vasta, Andrea Novara, Emilio Minerva, Enrico Matteoni, Filippo De Mattei, Giorgio Pellegrino et al. · 2025 · Journal of Neurology
  81. Marine Bioactive Components and Chronic Neuroinflammation: Focus on Neurodegenerative Disease
    Elda Favari, Cinzia Parolini · 2025 · Marine Drugs
  82. Neuronal TDP-43 pathology drives astrocytic interferon response in a mouse model of ALS
    Jie An, Nzinga E. Hendricks, Jeanna M. Wheeler, Joshua C. Hincks, Javier A. Ramos Benitez, Jessica M. Snyder, Brian C. Kraemer, Nicole F. Liachko, Keith B. Elkon · 2025 · Journal of Neuroinflammation
  83. Diagnostic utility of threshold tracking TMS paradigms in early amyotrophic lateral sclerosis
    Aicee Dawn Calma, Nathan Pavey, Cláudia Santos Silva, Mehdi A. J. van den Bos, Con Yiannikas, Michelle Anne Farrar, Matthew C. Kiernan, Parvathi Menon, Steve Vucic · 2025 · Clinical Neurophysiology
  84. The role of glial cells in amyotrophic lateral sclerosis
    Virenkumar A. Pandya, Rickie Patani · 2024 · International review of neurobiology
  85. Nerve fibre degeneration in the brain in amyotrophic lateral sclerosis
    Martin R. Turner · 2012 · Journal of Neurology Neurosurgery & Psychiatry
  86. Kv1.3 In Microglia: Neuroinflammatory Determinant and Promising Pharmaceutical Target
    Antônio Felipe · 2018 · Journal of Neurology and Neuromedicine
  87. Chapter 16 Primary lateral sclerosis
    Andrew Eisen · 2007 · Handbook of clinical neurology
  88. PET Imaging of Translocator Protein Expression in Neurological Disorders
    David James Brooks · 2020 · Springer eBooks
  89. Multiple Routes of Motor Neuron Degeneration in ALS
    Jin Hee, Jae sung Keun · 2013 · InTech eBooks
  90. Increased Incidence of Amyotrophic Lateral Sclerosis in Polymyositis: A Nationwide Cohort Study
    Chia‐Chun Tseng, Shun‐Jen Chang, Wen‐Chan Tsai, Tsan‐Teng Ou, Cheng‐Chin Wu, Wan‐Yu Sung, Ming‐Chia Hsieh, Jeng‐Hsien Yen · 2016 · Arthritis Care & Research
  91. Positron emission tomography and single-photon emission computed tomography in central nervous system drug development
    David James Brooks · 2005 · Neurotherapeutics
  92. Neuroglia in neurodegeneration: Amyotrophic lateral sclerosis and frontotemporal dementia
    Fabiola De Marchi, Edoardo Gioele Spinelli, Caterina Bendotti · 2025 · Handbook of clinical neurology
  93. C9orf72 Repeat Expansion Induces Metabolic Dysfunction in Human iPSC ‐Derived Microglia and Modulates Glial‐Neuronal Crosstalk
    Marika Mearelli, Insa Hirschberg, Christin Weissleder, Carmela Giachino, Maria Jose Perez J., Malvina Dubroux, Francesca Provenzano, Mafalda Rizzuti, Linda Ottoboni, Udit Sheth et al. · 2025 · Glia
  94. Elucidating the neuroimmunology of traumatic brain injury: methodological approaches to unravel intercellular communication and function
    Hadi Abou‐El‐Hassan, Joshua D. Bernstock, Joshua I. Chalif, Taha Yahya, Rafael Machado Rezende, Howard L. Weiner, Saef Izzy · 2023 · Frontiers in Cellular Neuroscience
  95. New developments in pre-clinical models of ALS to guide translation
    Lenja De Cock, Valérie Bercier, Ludo Van Den Bosch · 2024 · International review of neurobiology
  96. Microglial Imaging in Movement Disorders With PK11195 PET
    Seong‐Beom Koh · 2008 · Journal of Movement Disorders
  97. Novel therapeutic approaches for motor neuron disease
    Luca Muzio, Alma Ghirelli, Federica Agosta, Gianvito Martino · 2023 · Handbook of clinical neurology
  98. Abnormalities of cortical stimulation strength-duration time constant in amyotrophic lateral sclerosis
    Nathan Pavey, Parvathi Menon, Angel V. Peterchev, Matthew C. Kiernan, Steve Vucic · 2024 · Clinical Neurophysiology
  99. Myelin measurement in amyotrophic lateral sclerosis with synthetic MRI: A potential diagnostic and predictive method
    Megumi Toko, Tomohiko Ohshita, Masahiro Nakamori, Hiroki Ueno, Yuji Akiyama, Hirofumi Maruyama · 2024 · Journal of the Neurological Sciences
  100. Adenosine Receptors and Neuroinflammation
    Antonella Ferrante, Roberta De Simone, Maria Antonietta Ajmone‐Cat, Luisa Minghetti, Patrizia Popoli · 2018 · Springer eBooks